A clinicopathological and molecular analysis of glioblastoma multiforme with long-term survival

Journal of Clinical Neuroscience

Volumn 18, Issue 1, 2011, Pages 66-70

  Das, Prasenjit ^a   Puri, Tarun ^a   Jha, Prerana ^a   Pathak, Pankaj ^a   Joshi, Nikhil ^a   Suri, Vaishali ^a   Sharma, Mehar Chand ^a   Sharma, Bhawani S ^a   Mahapatra, A K ^a   Suri, Ashish ^a   Sarkar, Chitra ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Glioblastoma; Long term survival; Molecular background; Radiotherapy; Temozolomide

Indexed keywords

6 O METHYLGUANINE; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; TEMOZOLOMIDE;

ADJUVANT CHEMOTHERAPY; ARTICLE; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; SEX RATIO;

ADULT; AGE OF ONSET; BRAIN NEOPLASMS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PROGNOSIS; PROMOTER REGIONS, GENETIC; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 78650179843     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.04.050     Document Type: Article

References (45)

1. Burger PC, Scheithauer BW, Vogel FS, editors. The brain tumors. In Surgical pathology of the central nervous system and its coverings. 4th ed. New York: Churchill Livingstone; 2002. p. 180-98.
2. T. Homma, T. Fukushima, and S. Vaccarella Correlation among pathology, genotype, and patient outcomes in glioblastoma J Neuropathol Exp Neurol 65 2006 846 854 (Pubitemid 44371230)
3. E.C. Burton, K.R. Lamborn, and P. Forsyth Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors Clin Cancer Res 8 2002 180 187 (Pubitemid 34101475)
4. R.E. McLendon, and E.C. Halperin Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 98 2003 1745 1748 (Pubitemid 37238632)
5. J.A. Kraus, N. Glesmann, and M. Beck Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme J Neurooncol 48 2002 89 94
6. P. Deb, M.C. Sharma, and A.K. Mahapatra Glioblastoma multiforme with long term survival Neurol India 53 2005 329 333
7. M.J. Tait, T.V. Petrik, and A. Loosemore Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases Br J Neurosurg 21 2007 496 500 (Pubitemid 47537162)
8. J.N. Scott, N.B. Rewcastle, and P.M. Brasher Which glioblastoma multiforme patient will become a long-term survivor? A population-based study Ann Neurol 46 1999 183 188 (Pubitemid 29382874)
9. R. Stupp, W.R. Mason, and M.J. Van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996 (Pubitemid 40349501)
10. Metcalfe SE, Grant R. Biopsy versus resection for malignant glioma. 2001. Cochrane database Syst Rev, 3: CD002034. < http://www.ncbi.nlm.nih.gov/ pubmed/11687008 >.
11. H. Ohgaki, A. Peraud, and Y. Nakazato Giant cell glioblastoma P. Kleihues, W.K. Cavenee, WHO classification of tumors: pathology and genetics of tumors of the nervous system 2002 IARC Press Lyon 40 41
12. M.C. Schmidt, S. Antweiler, and N. Urban Impact of genotype and morphology on the prognosis of glioblastoma J Neuropathol Exp Neurol 61 2002 321 328 (Pubitemid 34266783)
13. F.F. Lang, D.C. Miller, and M. Koslow Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors J Neurosurg 81 1994 427 436 (Pubitemid 24267651)
14. C. Gianni, E.J. Reushing, and Hainfellaer Hemangiopericytoma D.N. Louis, H. Ihgaki, O.D. Wiestler, WHO classification of tumors of central nervous system 2007 IARC Press Lyon 178 180
15. K. Dietmar, K. Barbara, and H. Christian Long-term survival with glioblastoma multiforme Brain 130 2007 2596 2606
16. M.E. Hegi, A.C. Diserens, and T. Gorlia MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003 (Pubitemid 40349502)
17. J.A. Kraus, J. Koopmann, and P. Kaskel Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma J Neuropathol Exp Neurol 54 1995 91 95
18. J.S. Smith, A. Perry, and T.J. Borell Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas and mixed oligo-astrocytomas J Clin Oncol 18 2000 636 645 (Pubitemid 30078545)
19. T. Nagasaka, M. Gunji, and N. Hosokai FISH 1p/19q deletion/imbalance for molecular sub classification of glioblastoma Brain Tumor Pathol 24 2007 1 5 (Pubitemid 46836348)
20. M.P. Myers, I. Pass, and I.H. Batty The lipid phosphatase activity of PTEN is critical for its tumor suppressor function Proc Natl Acad Sci U S A 95 1998 13513 13518 (Pubitemid 28523003)
21. J.K. Wiencke, S. Zheng, and N. Jelluma Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma Neuro-oncol 9 2007 271 279 (Pubitemid 47169659)
22. D.J. Brat, B.M. Shehata, and A.A. Castellano-Sanchez Congenital glioblastoma: a clinicopathologic and genetic analysis Brain Pathol 17 2007 276 281 (Pubitemid 47000636)
23. G. Choe, S. Horvath, and T.F. Cloughesy Analysis of the phosphatidylinositol 3-kinase signalling pathway in glioblastoma patients in vivo Cancer Res 63 2003 2742 2746
24. A. Korshunov, R. Sycheva, and S. Gorelyshev Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood Mod Pathol 18 2005 1258 1263 (Pubitemid 43079926)
25. D. Krex, B. Klink, and C. Hartmann Long-term survival with glioblastoma multiforme Brain 130 2007 2596 2606 (Pubitemid 47511715)
26. U. Pichlmeier, T. Meinel, and O.D. Wiestler Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial Lancet Oncol 7 2006 359 360
27. L.A. Stewart Chemotherapy in adult high-grade gliomas: a systematic review and meta-analysis of individual patient data from 12 randomized trials Lancet 359 2002 1011 1018 (Pubitemid 34286538)
28. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
29. R. Stupp, P.Y. Dietrich, and K.S. Ostermann Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide J Clin Oncol 20 2002 1375 1382 (Pubitemid 34177445)
30. D.A. Hilton, M. Penney, and L. Pobereskin Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival Histopathology 44 2004 555 560 (Pubitemid 38845101)
31. M.C. Huang, O. Kubo, and Y. Tajka A clinico-immunohistochemical study of giant cell glioblastoma Noshuyo Byori 13 1996 11 16
32. P.C. Burger, and R.T. Vollmer Histologic factors of prognostic significance in the glioblastoma multiforme Cancer 46 1980 1179 1186 (Pubitemid 10043487)
33. J.C. Margetts, and R. Kalyan Giant-celled glioblastoma of brain. A clinico-pathological and radiological study of ten cases (including immunohistochemistry and ultrastructure) Cancer 63 1989 524 531 (Pubitemid 19038469)
34. N. Shinojima, M. Kochi, and J. Hamada The influence of sex and the presence of giant cells on post-operative long term survival in adult patients with supratentorial glioblastoma multiforme J Neurosurg 97 2004 1203 1207
35. P.C. Burger, and S.B. Green Patient age, histologic features and length of survival in patients with glioblastoma multiforme Cancer 59 1987 1617 1625 (Pubitemid 17060106)
36. M.A. Hammound, R. Sawarya, and W. Shi Prognostic significance of preoperative MRI scans in glioblastoma multiforme J Neurooncol 27 1996 65 73
37. A. Pierlenni, M. Bonamini, and P. Pantano Radiological assessment of necrosis in glioblastoma, variability and prognostic value Neuroradiology 40 1988 150 153
38. A.B. Heimberger, D. Suki, and D. Yang J Transl Med 3 2005 38
39. N. Pore, S. Liu, and D.A. Haas-Kogan PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter Cancer Res 63 2003 236 241 (Pubitemid 36070445)
40. A.M. Stark, P. Witzel, and R.J. Strege P53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme J Neurol Neurosurg Psychiatry 74 2003 779 783 (Pubitemid 36628293)
41. M.C. Ribeiro, L.M.B. Coutinho, and A. Hilbig The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma multiforme Arq Neuropsiquiatr 62 2004 262 270 (Pubitemid 38715310)
42. M.E. Hegi, A.C. Diserens, and S. Godard Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide Clin Cancer Res 10 2004 1871 1874 (Pubitemid 38375541)
43. Jha P, Suri V, Jain A, et al. O6-methylguanine DNA methyltransferase (MGMT) gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment. Neurosurgery 2010; in press.
44. L. Wang, Q. Wei, and L.E. Wang Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation J Clin Oncol 24 2006 1627 1632 (Pubitemid 46638787)
45. D.J. Brat, W.F. Seiferheld, and A. Perry Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from radiation. Therapy oncology group trials Neurooncology 6 2004 96 103 (Pubitemid 38455755)